Leukocyte-reduction to prevent transfusion-transmitted cytomegalovirus infections

Pediatric Transplantation

Volumn 3, Issue SUPPL. 1, 1999, Pages 19-22

  Strauss, Ronald G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cytomegalovirus; Leukocyte reduction; Leukofiltration; Transfusion transmitted cytomegalovirus

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CYTOMEGALOVIRUS INFECTION; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; SERODIAGNOSIS; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; LEUKAPHERESIS; MALE; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0032698351     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.1999.00048.x     Document Type: Article

References (13)

1. AMERICAN ASSOCIATION OF BLOOD BANKS. Association Bulletin No. 9702. Leukocyte reduction for the prevention of transfusion-transmitted cytomegalovirus. Bethesda, MD: AABB Press, 1997, 1-11.
2. VERDONCK LF, DE GRAAN-HENTZEN YCE, DEKKER AW, et al. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation. Bone Marrow Transplant 1987: 2: 73-78.
3. DE GRAAN-HENTZEN YCE, GRATAMA JW, MUDDE GC, et al. Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 1989: 29: 757-760.
4. MURPHY MF, GRINT PCA, HARDIMAN AE, et al. Use of leucocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukaemia. Br J Haematol 1988: 70: 253-254.
5. GILBERT GL, HAYES K, HUDSON IL, et al. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Lancet 1989: 1: 1228-1231.
6. EISENFELD L, SILVER H, MCLAUGHLIN J, et al. Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion 1992: 32: 205-209.
7. ANDREU G. Role of leukocyte depletion in the prevention of transfusion-induced cytomegalovirus infection. Semin Hematol 1991: 28: 26-31.
8. BACIGALUPO A, TEDONE E, SANNA MA, et al. CMV infections following allogeneic BMT. risk factors, early treatment and correlation with transplant related mortality. Haematologica 1992: 77: 507-513.
9. VAN PROOIJEN HC, VISSER JJ, VAN OOSTENDORP WR, et al. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. Br J Haematol 1994: 87: 144-147.
10. BOWDEN RA, SLICHTER SJ, SAYERS M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995: 86: 3598-3603.
11. ADLER SP. Data that suggest that FFP does not transmit CMV (Letter). Transfusion 1988: 28: 604.
12. BOWDEN R, SAYERS M. The risk of transmitting cytomegalovirus infection by fresh frozen plasma. Transfusion 1990: 30: 762-763.
13. HILLYER CD, EMMENS RK, ZAGO-NOVARETTI M, BERKMAN EM. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion 1994: 34: 929-934.